SFL’s CEO Shayesteh Fürst-Ladani, Director of Regulatory Affairs Suzanne Einmahl, and Business Development Manager Delphine Guerin, are participating in the Biotechgate digital partnering business development event (31 August‑3 September, online). The SFL Team are looking forward to discuss how SFL can support global and local Pharma and Biotech companies in their product development.

SFL provides strategic and operational support for projects covering all life-cycle stages from early development and registration of new products, to regulatory maintenance and market access activities of approved healthcare products, utilizing its unique combination of expertise and a multi-disciplinary approach. In addition, SFL can also act as the Marketing Authorization Holder (MAH) for pharma companies, who do not have a registered subsidiary in the EU or in Switzerland. Contact us to arrange a 1‑1 partnering meeting with Shayesteh, Suzanne or Delphine during the Biotechgate event.